<p>A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH at the<strong> </strong>European Society for Medical Oncology (ESMO) Congress 2023.</p>